Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease

NCT00843518 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00843518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00843518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease
Lead sponsor
Eli Lilly and Company
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2009
Completion date
June 30, 2011
Enrollment
132 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease